Recruiting

Light Therapy

Sponsor:

Efforia, Inc

Code:

NCT07298382

Conditions

Skin

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

Blue Light Therapy

Study Details

Brief summary:

Participants will experience a rejuvenating twice-weekly light therapy journey that blends the power of blue, red, and infrared light. Each 20-minute session flows through three phases: starting with refreshing blue light to awaken and energize, then moving into soothing red light, and finishing with deeply nourishing infrared light. This unique protocol is designed to help unlock healthier-looking skin and boost your natural glow.

Conditions

Skin

Study ID

NCT07298382

Start date

Oct 6, 2025

Status verified date

Nov, 2025

Completion date

Oct 6, 2026

Anticipated

Primary completion date

Oct 6, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion Criteria:

  • Individuals with Epilepsy
  • Individuals with Photosensitivity
  • Individuals with eye conditions
  • Pregnant individuals
  • Individuals with skin sensitivity
  • Individuals taking certain light-sensitive medications

Study Design

Enrollment

100 participants

Anticipated

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: Single Arm longitudinal where participants act as their own control

Single Arm longitudinal where participants act as their own control

Interventions

Blue Light Therapy

Blue Light Therapy therapy, combining blue, red, and infrared light, has been backed by studies showing improved skin health and reduced signs of aging. The medical community generally supports light therapy for its non-invasive nature and potential benefits, though results can vary. Social media buzz highlights glowing testimonials, while the general population views it as a promising skincare enhancement with minimal risks. Benefits include improved complexion and reduced acne, with risks being rare and minor, such as temporary redness.

Treatment:

First 5 Minutes 450nm (Blue) Second 5 Minutes 450nm (Blue) 660nm (Red) 810nm (Infrared) Final 10 Minutes 660nm (Red) 810nm (Infrared)

Primary outcome measure

  • Comprehensive Weekly Skin Health Self-Assessment [ Time Frame: Baseline through Day 30 (weekly assessments) ]
  • Dermatology Life Quality Index (DLQI) [ Time Frame: Baseline through Day 30 (weekly assessments) ]
  • Facial Skin Self-Assessment Survey [ Time Frame: Baseline through day 30 (weekly assessments) ]

Central Contacts and Locations

Central contacts

Matthew Amsden

(646) 679-2479help@efforia.com

Locations

Efforia

Recruiting

New York, New York, United States, 10003

Contacts

Matthew Amsden

(646) 679-2479help@efforia.com

More Information

Sponsor

Efforia, Inc

Last update posted

Dec 23, 2025

Last verified

Nov, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Efforia, Inc on 2025-12-23.